Ketamine improves survival and suppresses IL-6 and TNFalpha production in a model of Gram-negative bacterial sepsis in rats

Resuscitation

Volumn 62, Issue 2, 2004, Pages 237-242

  Shaked, Gad ^a   Czeiger, David ^b   Dukhno, Oleg ^a   Levy, Isaac ^b   Artru, Alan A ^c   Shapira, Yoram ^b   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Anaesthesia; Anestesia; Choque; Choque s ptico; Infec o; Infecci n; Infection; Inflammatory response; NMDA receptor; Receptor NMDA; receptor NMDA; Resposta inflamat ria; Respuesta inflamatoria; Septic shock; Shock

Indexed keywords

CYTOKINE; INTERLEUKIN 6; KETAMINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COLONY FORMING UNIT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; ESCHERICHIA COLI; GRAM NEGATIVE SEPSIS; INFLAMMATORY CELL; INOCULATION; MALE; MEASUREMENT; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; SURVIVAL RATE;

ANESTHETICS, DISSOCIATIVE; ANIMALS; ESCHERICHIA COLI INFECTIONS; INTERLEUKIN-6; KETAMINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3843124277     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2004.02.015     Document Type: Article

References (33)

1. Baue A.E., Durham R., Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock. 10:1998;79-89
2. Taniguchi T., Shibata K., Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology. 95:2001;928-932
3. Weigand M.A., Schmidt H., Zhao Q., Martin E., Bardenheuer H.J. Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth. Analg. 90:2000;206-212
4. Lippmann M., Appel P.L., Mok M.S., Shoemaker W.C. Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients. Crit. Care Med. 11:1983;730-734
5. Yu Y., Zhou Z., Xu J., Liu Z., Wang Y. Ketamine reduces NFkappaB activation and TNFalpha production in rats mononuclear cells induced by lipopolysaccharide in vitro. Ann. Clin. Lab. Sci. 32:2002;292-298
6. Kawasaki T., Ogata M., Kawasaki C., Ogata J., Inoue Y., Shigematsu A. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth. Analg. 89:1999;665-669
7. Busund R., Balteskard L., Ronning G., Hogasen K., Revhaug A. Fatal myocardial depression and circulatory collapse associated with complement activation induced by plasma infusion in severe porcine sepsis. Acta Anaesthesiol. Scand. 39:1995;100-108
8. Modig J. Positive effects of ketamine vs. metomidate anesthesia on cardiovascular function, oxygen delivery and survival. Studies with a porcine endotoxin model. Acta Chir. Scand. 153:1987;7-13
9. Worek F.S., Blumel G., Zeravik J., Zimmermann G.J., Pfeiffer U.J. Comparison of ketamine and pentobarbital anesthesia with the conscious state in a porcine model of Pseudomonas aeruginosa septicemia. Acta Anaesthesiol. Scand. 32:1988;509-515
10. Koga K., Ogata M., Takenaka I., Matsumoto T., Shigematsu A. Ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan-sensitized endotoxin shock model. Circ. Shock. 44:1994;160-168
11. Sands K.E., Bates D.W., Lanken P.N., et al. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA. 278:1997;234-240
12. Imai T., Takahashi K., Masuo F., Goto F. Anaesthesia affects outcome of sepsis in mice. Can. J. Anaesth. 45:1998;360-366
13. Hansbrough J.F., Zapata-Sirvent R.L., Bartle E.J., et al. Alterations in splenic lymphocyte subpopulations and increased mortality from sepsis following anesthesia in mice. Anesthesiology. 63:1985;267-273
14. Orser B.A., Pennefather P.S., MacDonald J.F. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology. 86:1997;903-917
15. Roytblat L., Roy-Shapira A., Greemberg L., et al. Preoperative low dose ketamine reduces serum interleukin-6 response after abdominal hysterectomy. Pain Clin. 9:1996;327-334
16. Roytblat L., Talmor D., Rachinsky M., et al. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth. Analg. 87:1998;266-271
17. Hofbauer R., Moser D., Hammerschmidt V., Kapiotis S., Frass M. Ketamine significantly reduces the migration of leukocytes through endothelial cell monolayers. Crit. Care Med. 26:1998;1545-1549
18. Shimaoka M., Lida T., Ohara A., et al. Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br. J. Anaesth. 77:1996;238-242
19. Lewis E., Rogachev B., Shaked G., Douvdevani A. The in vitro effects of ketamine at large concentrations can be attributed to a nonspecific cytostatic effect. Anesth. Analg. 92:2001;927-929
20. Darville T., Giroir B., Jacobs R. The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy. Infection. 21:1993;279-290
21. Heumann D., Glauser M.P., Calandra T. Molecular basis of host-pathogen interaction in septic shock. Curr. Opin. Microbiol. 1:1998;49-55
22. Strieter R.M., Kunkel S.L., Bone R.C. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit. Care Med. 21:1993;S447-S463
23. Beutler B., Milsark I.W., Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869-871
24. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 73:1999;309-321
25. Harris R.L., Musher D.M., Bloom K., et al. Manifestations of sepsis. Arch. Intern. Med. 147:1987;1895-1906
26. Levi M., ten Cate H., van der Poll T., van Deventer S.J. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA. 270:1993;975-979
27. Shalaby M.R., Waage A., Aarden L., Espevik T. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53:1989;488-498
28. Casey L.C., Balk R.A., Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:1993;771-778
29. Cruickshank A.M., Fraser W.D., Burns H.J., Van Damme J., Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin. Sci. 79:1990;161-165
30. Waisbren B.A. Gram-negative shock and endoxin shock. Am. J. Med. 36:1964;819-824
31. Karzai W., Cui X., Mehlhorn B., et al. Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats. Anesthesiology. 99:2003;81-89
32. Booth NH. Nonnarcotic analgesics. In: Booth NH, McDonald LE, editors. Veterinary pharmacology and therapeutics. Ames, IA: Iowa State University Press; 1988. p. 340-61.
33. Reves JG, Glass PSA, Lubarsky DA. Nonbarbiturate intravenous anesthetics. In: Miller RD, editor. Anesthesia. Philadelphia, PA: Churchill Livingstone; 2000. p. 228-72.